Researchers at the University of Connecticut have found a new way to identify protein mutations in cancer cells. The novel method is being used to develop precision medical vaccines to treat … Continue Reading Researchers develop first individualised precise medical vaccine for ovarian cancer.
Ovarian cancer is the most deadly gynecological cancer, claiming the lives of more than 50% of women who are diagnosed with the disease. A study involving the University of Ottawa … Continue Reading Researchers identify protein ‘protector’ of chemo-resistant ovarian cancer cells.
Over the years researchers have made tremendous strides in the understanding and treatment of cancer by searching genomes for links between genetic alterations and disease. Most of those studies have … Continue Reading Penn team mine specific ovarian cancer oncogene in ‘junk DNA’.
Scientists at A*STAR’s Institute of Medical Biology (IMB) have found new clues to early detection and precision treatment of ovarian cancer, currently one of the most difficult cancers to diagnose … Continue Reading A*STAR scientists make breakthroughs in ovarian cancer research.
Researchers with The Cancer Genome Atlas (TCGA) Research Network have completed the largest, most diverse tumour genetic analysis ever conducted, revealing a new approach to classifying cancers. The work, led … Continue Reading Largest-ever cancer genetic analysis reveals new way of classifying cancer.